4055

531349

PANACEABIO

img img img img
No Data Available

PANACEA BIOTEC LTD Share Price Update

As of the latest trading session, PANACEA BIOTEC LTD is trading at ₹412.85, down by ₹-0.29 or -0.07% from its previous close. The stock has moved between ₹409.05 and ₹427.40 today. Over the past year, the stock has delivered a return of -20.78%. In the last month, it has returned 11.35%.

PANACEA BIOTEC LTD performance

Today’s low Today’s high
₹ 409.05 ₹ 427.40
₹ 412.85
52 week low 52 week high
₹ 292.40 ₹ 547.75
₹ 412.85
Open Price ₹ 414.45
Prev. Close ₹ 413.15
Volume (Shares) 99419.00
Total traded value ₹ 410.45
Upper Circuit ₹ 495.75
Lower Circuit ₹ 330.55
info

Investment Returns

Over 1 Month 11.35% Over 3 Months 26.48% Over 6 Months 13.81% Over 1 Year -20.78%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

PANACEA BIOTEC LTD fundamentals


  • Market cap (Cr) 2,528.70
  • P/E Ratio (TTM) -60.03
  • Beta 0.97
  • Book Value / share 47.61
  • Return on equity 0.00%
  • EPS (TTM) 0.00
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) -7.36
info icon alternate text
  • Market cap (Cr) 2,526.00
  • P/E Ratio (TTM) -60.03
  • Beta 0.80
  • Book Value / share 47.61
  • Return on equity 0.00%
  • EPS (TTM) 0.00
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) -7.36
info icon alternate text

PANACEA BIOTEC LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 99.31
Operating Expense 112.62
Net Profit -7.36
Net Profit Margin (%) -7.41
Earnings Per Share (EPS) -1.20
EBITDA 2.45
Effective Tax Rate (%) 22.28
Particulars SEP 2025 (Values in Cr)
Revenue 90.81
Operating Expense 115.35
Net Profit -15.64
Net Profit Margin (%) -17.22
Earnings Per Share (EPS) -2.55
EBITDA -10.09
Effective Tax Rate (%) 25.27
Particulars JUN 2025 (Values in Cr)
Revenue 112.25
Operating Expense 126.04
Net Profit -6.70
Net Profit Margin (%) -5.96
Earnings Per Share (EPS) -1.09
EBITDA 1.92
Effective Tax Rate (%) 24.20
Particulars MAR 2025 (Values in Cr)
Revenue 67.90
Operating Expense 96.02
Net Profit -12.39
Net Profit Margin (%) -18.24
Earnings Per Share (EPS) -2.02
EBITDA -12.48
Effective Tax Rate (%) 43.75
Particulars DEC 2024 (Values in Cr)
Revenue 108.43
Operating Expense 102.10
Net Profit 9.65
Net Profit Margin (%) 8.89
Earnings Per Share (EPS) 1.58
EBITDA 18.71
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 309.85
Operating Expense 352.53
Net Profit -15.23
Net Profit Margin (%) -4.91
Earnings Per Share (EPS) -2.49
EBITDA 9.69
Effective Tax Rate (%) 41.55
Particulars MAR 2024 (Values in Cr)
Revenue 359.60
Operating Expense 380.29
Net Profit 3.55
Net Profit Margin (%) 0.98
Earnings Per Share (EPS) 0.58
EBITDA 39.08
Effective Tax Rate (%) 15.67
Particulars MAR 2023 (Values in Cr)
Revenue 257.07
Operating Expense 354.25
Net Profit -87.54
Net Profit Margin (%) -34.05
Earnings Per Share (EPS) -14.29
EBITDA -28.18
Effective Tax Rate (%) -39.50
Particulars MAR 2022 (Values in Cr)
Revenue 235.50
Operating Expense 341.65
Net Profit -93.58
Net Profit Margin (%) -39.73
Earnings Per Share (EPS) -15.28
EBITDA -60.10
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 343.56
Operating Expense 377.15
Net Profit -14.44
Net Profit Margin (%) -4.20
Earnings Per Share (EPS) -2.35
EBITDA 21.24
Effective Tax Rate (%) -12.14
Particulars MAR 2025 (Values in Cr)
Book Value / Share 132.76
ROE % -5.13
ROCE % -4.31
Total Debt to Total Equity 0.02
EBITDA Margin -0.77
Particulars MAR 2024 (Values in Cr)
Book Value / Share 133.94
ROE % -4.07
ROCE % -3.34
Total Debt to Total Equity 0.02
EBITDA Margin 1.07
Particulars MAR 2023 (Values in Cr)
Book Value / Share 134.20
ROE % -11.06
ROCE % -9.50
Total Debt to Total Equity 0.03
EBITDA Margin -11.22
Particulars MAR 2022 (Values in Cr)
Book Value / Share 139.59
ROE % -60.80
ROCE % -5.11
Total Debt to Total Equity 1.32
EBITDA Margin -0.34
Particulars MAR 2021 (Values in Cr)
Book Value / Share -40.87
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 13.64
Particulars MAR 2025 (Values in Cr)
Book Value / Share 47.72
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.52
EBITDA Margin 3.13
Particulars MAR 2024 (Values in Cr)
Book Value / Share 50.20
ROE % 0.86
ROCE % 3.26
Total Debt to Total Equity 0.32
EBITDA Margin 10.86
Particulars MAR 2023 (Values in Cr)
Book Value / Share 49.63
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.24
EBITDA Margin -10.97
Particulars MAR 2022 (Values in Cr)
Book Value / Share 64.24
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.16
EBITDA Margin -25.52
Particulars MAR 2021 (Values in Cr)
Book Value / Share 79.43
ROE % -2.53
ROCE % -1.10
Total Debt to Total Equity 0.09
EBITDA Margin 5.22
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 106.96
Total Assets 1289.74
Total Liabilities 1289.74
Total Equity 830.61
Share Outstanding 6
Price to Book Ratio 9.23
Return on Assets (%) -0.64
Return on Capital (%) -0.98
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 139.48
Total Assets 1240.67
Total Liabilities 1240.67
Total Equity 838.22
Share Outstanding 6
Price to Book Ratio 2.42
Return on Assets (%) -0.09
Return on Capital (%) -0.14
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 225.99
Total Assets 1271.16
Total Liabilities 1271.16
Total Equity 840.11
Share Outstanding 6
Price to Book Ratio 2.18
Return on Assets (%) -2.61
Return on Capital (%) -3.86
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 583.27
Total Assets 1758.86
Total Liabilities 1758.86
Total Equity 873.65
Share Outstanding 6
Price to Book Ratio 2.31
Return on Assets (%) 61.30
Return on Capital (%) 118.78
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 135.79
Total Assets 1177.53
Total Liabilities 1177.53
Total Equity -231.69
Share Outstanding 6
Price to Book Ratio 2.23
Return on Assets (%) -12.54
Return on Capital (%) -25.13
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 62.16
Total Assets 869.46
Total Liabilities 869.46
Total Equity 313.96
Share Outstanding 6
Price to Book Ratio 9.23
Return on Assets (%) -1.75
Return on Capital (%) -2.81
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 11.95
Total Assets 753.79
Total Liabilities 753.79
Total Equity 329.14
Share Outstanding 6
Price to Book Ratio 2.42
Return on Assets (%) 0.47
Return on Capital (%) 0.78
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 43.25
Total Assets 723.90
Total Liabilities 723.90
Total Equity 325.65
Share Outstanding 6
Price to Book Ratio 2.18
Return on Assets (%) -12.09
Return on Capital (%) -20.45
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 42.68
Total Assets 761.83
Total Liabilities 761.83
Total Equity 415.09
Share Outstanding 6
Price to Book Ratio 2.31
Return on Assets (%) -12.28
Return on Capital (%) -18.74
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 88.96
Total Assets 791.56
Total Liabilities 791.56
Total Equity 508.16
Share Outstanding 6
Price to Book Ratio 2.23
Return on Assets (%) -1.82
Return on Capital (%) -2.53
Particulars MAR 2025 (Values in Cr)
Net Income -7.94
Cash from Operations -26.40
Cash from Investing 64.98
Cash from Financing -2.66
Net change in Cash 34.95
Free Cash Flow 23.90
Particulars MAR 2024 (Values in Cr)
Net Income 1.47
Cash from Operations 2.40
Cash from Investing 10.22
Cash from Financing -2.80
Net change in Cash 7.31
Free Cash Flow 80.12
Particulars MAR 2023 (Values in Cr)
Net Income 12.80
Cash from Operations -419.97
Cash from Investing 430.33
Cash from Financing -18.37
Net change in Cash -10.49
Free Cash Flow -379.02
Particulars MAR 2022 (Values in Cr)
Net Income 1449.35
Cash from Operations 295.25
Cash from Investing 1282.57
Cash from Financing -1175.85
Net change in Cash -1.72
Free Cash Flow 307.76
Particulars MAR 2021 (Values in Cr)
Net Income -145.03
Cash from Operations 107.75
Cash from Investing -47.67
Cash from Financing -47.11
Net change in Cash 11.97
Free Cash Flow 129.52
Particulars MAR 2025 (Values in Cr)
Net Income -26.05
Cash from Operations 5.04
Cash from Investing -60.60
Cash from Financing 90.07
Net change in Cash 33.41
Free Cash Flow 58.01
Particulars MAR 2024 (Values in Cr)
Net Income 4.20
Cash from Operations 34.95
Cash from Investing -46.80
Cash from Financing 12.81
Net change in Cash -0.91
Free Cash Flow 110.47
Particulars MAR 2023 (Values in Cr)
Net Income -62.75
Cash from Operations -9.65
Cash from Investing 2.41
Cash from Financing 9.00
Net change in Cash 0.67
Free Cash Flow 28.72
Particulars MAR 2022 (Values in Cr)
Net Income -93.57
Cash from Operations -51.86
Cash from Investing 39.54
Cash from Financing 9.82
Net change in Cash -3.32
Free Cash Flow -43.81
Particulars MAR 2021 (Values in Cr)
Net Income -12.88
Cash from Operations 39.24
Cash from Investing -37.32
Cash from Financing -7.20
Net change in Cash -6.25
Free Cash Flow 53.78
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 35.69 14.75 1.72 273.50 23.12 40.00
BLISS GVS PHARMA LTD. 424.80 34.37 3.76 4493.92 118.35 437.40
CIPLA LTD 1398.50 27.69 3.28 112970.91 1165.55 1672.20
FERMENTA BIOTECH LTD. 295.20 13.02 2.13 868.80 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 35.69 24.96 4.59 273.50 23.12 40.00
AMRUTAJAN HEALTH LTD 559.55 25.08 4.36 1617.69 490.00 789.95
ASTRAZENECA PHARMA IND LT 8671.45 113.25 24.83 21678.63 7630.00 10653.05
BLISS GVS PHARMA LTD. 424.80 45.68 3.89 4493.92 118.35 437.40

PANACEA BIOTEC LTD shareholding pattern

Holding
23.95%
72.47%
1.59%
1.96%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

PANACEA BIOTEC LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
412.85 -0.07 redarrow
red-green-graph indicator
3 Bearish
13 Bullish
  • 5 Days 415.50
  • 26 Days 392.40
  • 10 Days 411.10
  • 50 Days 376.70
  • 12 Days 408.70
  • 100 Days 371.40
  • 20 Days 398.80
  • 200 Days 375.20
418.98 PIVOT
First Support 401.22 First Resistance 430.92 Second Support 389.28 Second Resistance 448.68 Third Support 371.52 Third Resistance 460.62
RSI 59.84 ADX 36.63 MACD 16.32 Williams % R -34.81 Commodity Channel Index (CCI) 65.57
Date 2026-05-29 Week 75532.00 Same Day 44689.00 Month 83750.00
1 Year 0.97 3 Year 1.02
Over 1 Month
11.35% down
Over 1 Year
-20.78% down
Over 3 Months
26.48% down
Over 3 Years
49.96% down
Over 6 Months
13.81% down
Over 5 Years
0.13% down

PANACEA BIOTEC LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
19 Sep 2011 0.75 Final 21 Sep 2011 Equity shares
16 Sep 2010 0.25 Final 20 Sep 2010 Equity shares
19 Sep 2008 1.0 Final 23 Sep 2008 Equity shares
21 Sep 2007 1.0 Final 25 Sep 2007 Equity shares
12 Aug 2005 0.0 Final 17 Aug 2005 Equity shares
Ex-Date Old FV NEW FV Record Date
03 Feb 2003 10.0 1.0 11 Feb 2003
Dividend date Dividend amount Dividend type Record date Instrument type
19 Sep 2011 0.75 Final 21 Sep 2011 Equity shares
16 Sep 2010 0.25 Final 20 Sep 2010 Equity shares
19 Sep 2008 1.0 Final 23 Sep 2008 Equity shares
21 Sep 2007 1.0 Final 25 Sep 2007 Equity shares
12 Aug 2005 0.0 Final 17 Aug 2005 Equity shares
Ex-Date Old FV NEW FV Record Date
03 Feb 2003 10.0 1.0 11 Feb 2003

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Panacea Biotec Ltd?

Answer Field

Panacea Biotec Ltd share price is for NSE ₹ 412.85 & for BSE ₹ 415.00 as on May 29 2026 03:30 PM.

What is the Market Cap of Panacea Biotec Ltd Share?

Answer Field

The market cap of Panacea Biotec Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on May 29 2026 03:30 PM.

What is the 52 Week High and Low of Panacea Biotec Ltd?

Answer Field

The 52 Week High and Low of Panacea Biotec Ltd for NSE is ₹ 547.75 and ₹ 292.40 and for BSE is ₹ 555.15 and ₹ 293.10.

What is 1 year return for Panacea Biotec Ltd?

Answer Field

The 1 year returns on the stock has been -20.78%.

What is the P/E Ratio of Panacea Biotec Ltd Share?

Answer Field

As on May 29 2026 03:30 PM the price-to-earnings (PE) ratio for Panacea Biotec Ltd share is -60.03.

What is the PB ratio of Panacea Biotec Ltd Share?

Answer Field

As on May 29 2026 03:30 PM, the price-to-book (PB) ratio for Panacea Biotec Ltd share is 47.61.

How to Buy Panacea Biotec Ltd Share?

Answer Field

You can trade in Panacea Biotec Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Panacea Biotec Ltd Share on Bajaj Broking App?

Answer Field

To buy Panacea Biotec Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Panacea Biotec Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|